Prospects for Protective Potential of Moringa oleifera against Kidney Diseases

Abstract

Kidney diseases are regarded as one of the major public health issues in the world. The objectives of this study were: (i) to investigate the causative factors involved in kidney disease and the therapeutic aspects of Moringa oleifera, as well as (ii) the effectiveness of M. oleifera in the anti-inflammation and antioxidant processes of the kidney while minimizing all potential side effects. In addition, we proposed a hypothesis to improve M. oleifera based drug development. This study was updated by searching the key words M. oleifera on kidney diseases and M. oleifera on oxidative stress, inflammation, and fibrosis in online research databases such as PubMed and Google Scholar. The following validation checking and scrutiny analysis of the recently published articles were used to explore this study. The recent existing research has found that M. oleifera has a plethora of health benefits. Individual medicinal properties of M. oleifera leaf extract, seed powder, stem extract, and the whole extract (ethanol/methanol) can up-increase the activity of antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), while decreasing the activity of inflammatory cytokines such as TNF-α, IL-1β, IL-6, and COX-2. In our study, we have investigated the properties of this plant against kidney diseases based on existing knowledge with an updated review of literature. Considering the effectiveness of M. oleifera, this study would be useful for further research into the pharmacological potential and therapeutic insights of M. oleifera, as well as prospects of Moringa-based effective medicine development for human benefits.

Starch-Based Hydrogel Nanoparticles Loaded with Polyphenolic Compounds of Moringa Oleifera Leaf Extract Have Hepatoprotective Activity in Bisphenol A-Induced Animal Models

“…In contrast, the levels of Caspase-3 and Bax increased slightly in groups (G3 and G5) treated separately with MOLE and Encap. MOLE alone (0.8 ± 0.1 ng/mL) [ 69 ].…”

Box-Behnken design based optimization of phenolic extractions from Polygonum equisetiforme roots linked to its antioxidant and antibacterial efficiencies

“…While kanamycin exhibits an inhibition zone of 20 mm, 28 mm, against Klebsiella pneumonia, Escherichia coli, respectively, and 29 mm against Bacillus cereus and Staphylococcus aureus. Nature plants contain various useful compounds that linked to human health benefits Islam S. et al, 2010;Akter et al, 2021), many of them exhibited antibacterial potential against disease causing bacteria (Islam et al, 2009;Rahman et al, 2009;Sheikh et al, 2010). In this current study, the antibacterial activity of root extract indicates the future prospects to use as therapeutic antimicrobial.…”

Implication of Nanoparticles to Combat Chronic Liver and Kidney Diseases: Progress and Perspectives

“…The exposure of pathogens to increasing pathogen-associated molecular patterns (PAMPs) upregulates the expression of caspase 8, thereby leading to mitochondrial permeability transition (MPT) in the third possible pathway. MPT, in the presence of sufficient amounts of ATP, leads to the activation of cytochrome C and apoptotic peptidase activating factor 1 (Apaf-1), which in turn upregulates the expression of caspase 9, 3, 6, and 7 and thus leads to apoptosis [ 10 ]. On the other hands, MTP, in the case of severe ATP depletion, leads to necrosis.…”